Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4376
PUT
ProShares Ultra Semiconductors
USD
$2.95B
| $4.61M | ﹤0.01% |
87,700
-10,300
| -11% | -$547K |
|
4377
PUT
BlackSky Technology
BKSY
$1.19B
| $4.6M | ﹤0.01% |
245,200
-44,900
| -15% | -$915K |
|
4378
Mesa Laboratories
MLAB
$574M
| $4.59M | ﹤0.01% |
58,521
+24,343
| +71% | +$1.85M |
|
4379
PUT
Evercore
EVR
$11.8B
| $4.59M | ﹤0.01% |
13,500
+5,600
| +71% | +$1.8M |
|
4380
FIVE9
FIVN
$2.54B
| $4.59M | ﹤0.01% |
228,949
-54,887
| -19% | -$1.17M |
|
4381
Cooper Companies
COO
$14.5B
| $4.59M | ﹤0.01% |
55,951
-86,547
| -61% | -$6.48M |
|
4382
PRA Group
PRAA
$755M
| $4.58M | ﹤0.01% |
+258,917
| New | +$4.03M |
|
4383
CALL
Kyndryl
KD
$3.05B
| $4.58M | ﹤0.01% |
172,400
+11,500
| +7% | +$312K |
|
4384
iShares Gold Trust Micro
IAUM
$6.81B
| $4.58M | ﹤0.01% |
106,427
-24,605
| -19% | -$1.02M |
|
4385
ProShares Ultra Russell2000
UWM
$249M
| $4.57M | ﹤0.01% |
+97,257
| New | +$4.6M |
|
4386
CALL
Charles River Laboratories
CRL
$12.8B
| $4.57M | ﹤0.01% |
22,900
-12,800
| -36% | -$2.32M |
|
4387
Washington Trust Bancorp
WASH
$741M
| $4.57M | ﹤0.01% |
154,550
+122,221
| +378% | +$3.48M |
|
|
DQ
4388
PUT
Daqo New Energy
DQ
$996M
| $4.56M | ﹤0.01% |
154,700
-52,000
| -25% | -$1.59M |
|
4389
Rocket Pharmaceuticals
RCKT
$394M
| $4.56M | ﹤0.01% |
1,299,991
-370,936
| -22% | -$1.27M |
|
4390
Brookfield
BN
$108B
| $4.56M | ﹤0.01% |
99,364
-8,333
| -8% | -$380K |
|
|
ONC
4391
PUT
BeOne Medicines Ltd
ONC
$39.4B
| $4.56M | ﹤0.01% |
15,000
+3,100
| +26% | +$1.01M |
|
4392
Prudential
PUK
$35.2B
| $4.56M | ﹤0.01% |
146,412
+19,520
| +15% | +$559K |
|
4393
Dr. Reddy's Laboratories
RDY
$10.2B
| $4.56M | ﹤0.01% |
324,449
+190,167
| +142% | +$2.67M |
|
4394
CALL
Range Resources
RRC
$8.95B
| $4.55M | ﹤0.01% |
129,000
-192,300
| -60% | -$7.16M |
|
4395
Korn Ferry
KFY
$4.28B
| $4.54M | ﹤0.01% |
68,828
-10,662
| -13% | -$717K |
|
4396
CALL
Invesco CurrencyShares Swiss Franc Trust
FXF
$398M
| $4.54M | ﹤0.01% |
40,700
-15,600
| -28% | -$1.73M |
|
|
ACH
4397
Accendra Health
ACH
$214M
| $4.54M | ﹤0.01% |
1,622,011
-271,766
| -14% | -$971K |
|
4398
Limbach Holdings
LMB
$581M
| $4.54M | ﹤0.01% |
58,306
+18,105
| +45% | +$1.49M |
|
4399
First Hawaiian
FHB
$3.35B
| $4.53M | ﹤0.01% |
179,229
+155,228
| +647% | +$3.86M |
|
4400
PUT
Scotiabank
BNS
$108B
| $4.53M | ﹤0.01% |
61,500
+2,100
| +4% | +$143K |
|
Similar funds
Citadel Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,362 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
- Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
- Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.